Squamous Intraepithelial Lesions Clinical Trials

1 recruiting

Squamous Intraepithelial Lesions Trials at a Glance

6 actively recruiting trials for squamous intraepithelial lesions are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Bruges, Brussels, and Fuzhou. Lead sponsors running squamous intraepithelial lesions studies include First Affiliated Hospital of Wenzhou Medical University, Fujian Maternity and Child Health Hospital, and Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau.

Browse squamous intraepithelial lesions trials by phase

Treatments under study

About Squamous Intraepithelial Lesions Clinical Trials

Looking for clinical trials for Squamous Intraepithelial Lesions? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Squamous Intraepithelial Lesions trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Squamous Intraepithelial Lesions clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis

Anal CancerSquamous Cell CarcinomaSquamous Intraepithelial Lesions+3 more
Universitair Ziekenhuis Brussel296 enrolled8 locationsNCT07029152
Recruiting
Not Applicable

A Clinical Study on the Evaluation of BD114 for the Treatment HPV-16-Related Cervical HSIL

High-grade Squamous Intraepithelial Lesions (HSIL)
Shanghai BDgene Co., Ltd.12 enrolled1 locationNCT07170254
Recruiting
Not Applicable

Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection

HPV-Related Cervical CarcinomaHPV InfectionLow-Grade Squamous Intraepithelial Lesions+1 more
First Affiliated Hospital of Wenzhou Medical University40 enrolled1 locationNCT06052033
Recruiting

Effect of HPV Integration on Prognosis of Young Women With CIN2 in China

HPV InfectionHSIL, High Grade Squamous Intraepithelial LesionsCervical Intraepithelial Neoplasia+1 more
Fujian Maternity and Child Health Hospital300 enrolled20 locationsNCT05282095
Recruiting

Pilot study of Anal Neoplasia Treatment in people with HIV Evaluation and monitoring (short title: PANTHER)

Anal High Grade Squamous Intraepithelial Lesions (HSIL)Human Papillomavirus
University of New South Wales Sydney, NSW, Australia100 enrolled1 locationACTRN12624000154505
Recruiting

Conservative Management of HSIL in Patients With Future Pregnancy Aspiration

Cervical Intraepithelial NeoplasiaUterine Cervical DysplasiaSquamous Intraepithelial Lesions of the Cervix
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau200 enrolled1 locationNCT04783805